Oxford Population Health and SomaLogic deliver 28 million proteomic data points on China Kadoorie Biobank samples

BOULDER, Colo., March 13, 2023 (GLOBE NEWSWIRE) — SomaLogic, Inc., a leader in proteomics technology, recently completed the 7,000-plex assay on and delivered data for 4,000 plasma samples from the China Kadoorie Biobank (CKB), one of the world’s largest prospective studies. The SomaLogic team provided more than 28 million data points from the assay which will be combined with other available genetic, lifestyle, anthropometric and health outcome data to address a range of research questions. This work builds on a successful history of SomaScan® Platform utilization in some of the world’s largest population proteomics biobank projects, including the EPICMESA, Fenland, Whitehall II, HUNT3, CRIC, COPD Gene, Spiromics, deCODE and ARIC datasets.

Professor Zhengming Chen, Richard Peto Professor of Epidemiology at Oxford Population Health and UK-Principal Investigator of the China Kadoorie Biobank, said “The large-scale application of proteomics assays in big population biobanks such as CKB will be a game changer. Building on the experience gained in these initial 4,000 samples, we will seek to extend the use of the proteomic assay to a much larger number of samples in the near future.”

The China Kadoorie Biobank (www.ckbiobank.org) was established to investigate the main genetic and environmental causes of common chronic diseases in the Chinese population. Between 2004 and 2008, over 510,000 adults were recruited from ten geographically defined regions of China, with extensive data collection by questionnaire and physical measurements, and with long-term storage of blood samples for future study. All participants are now being monitored for fatal and non-fatal health outcomes through linkage with established registries and health insurance databases in the study areas.

This large, well-established study will be a uniquely powerful and rich resource for investigating the main causes of many common chronic diseases over the next few decades, and the information generated has the potential to improve understanding of disease etiology, risk prediction and development of new treatments. The project is a long-term collaboration between Oxford Population Health, Peking University and the Chinese Academy of Medical Sciences.

SomaLogic’s proprietary SomaScan Platform is designed to be a universal platform that can be applied across research and discovery, translational research and biopharmaceutical development, and clinical applications. SomaLogic can run approximately 7,000 protein measurements on a single 55 microliter plasma or serum sample. The company has run more than 550,000 samples to date.

About SomaLogic 
SomaLogic (Nasdaq: SLGC) seeks to deliver precise, meaningful and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from SomaLogic’s personalized measurement of important changes in an individual’s proteins over time. For more information, visit www.somalogic.com .

About Oxford Population Health
Oxford Population Health (the Nuffield Department of Population Health) is a world-leading research institute, based at the University of Oxford, that investigates the causes and prevention of disease.

We have over 750 staff, students and academic visitors working in a number of world-renowned population health research groups, including the Cancer Epidemiology Unit (CEU), Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), and the National Perinatal Epidemiology Unit (NPEU), and other groups working on public health, health economics, ethics and health record linkage. Oxford Population Health is also a key partner in the Oxford University Big Data Institute.

https://www.ndph.ox.ac.uk/

Forward Looking Statements Disclaimer
This press release contains certain forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. All statements, other than statements of historical fact included in this press release, regarding our strategy, future operations, financial position, estimated revenues, projections, prospects, plans and objectives of management are forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “forecast,” “guidance,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “continue,” “will likely result,” “possible,” “potential,” “predict,” “pursue,” “target” and similar expressions, although not all forward-looking statements contain such identifying words. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward-looking statements do not guarantee future performance and involve known and unknown risks, uncertainties and other factors.   Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including factors which are beyond SomaLogic’s control. You should carefully consider these risks and uncertainties, including, but not limited to, those factors described under Part I, Item 1A – “Risk Factors” in our Annual Report on Form 10-K and other filings we make with the Securities and Exchange Commission. These filings identify and address important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and SomaLogic assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The Company will not and does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Media Contact
Emilia Costales
720-798-5054
ecostales@somalogic.com

Investor Contacts
Lauren Glaser
Lglaser@somalogic.com

Marissa Bych
Gilmartin Group LLC
Marissa@gilmartinir.com

GlobeNewswire Distribution ID 8786241

ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep

  • 81% of respondents experience one or more symptoms indicating poor sleep quality, despite 64% saying they’re satisfied with the quantity of their sleep
  • Women and older generations are less satisfied with the quality and quantity of their sleep compared to the survey’s overall average
  • Annual survey aims to raise awareness for sleep health during National Sleep Awareness Week and World Sleep Day

SAN DIEGO, March 13, 2023 (GLOBE NEWSWIRE) — ResMed (NYSE: RMD, ASX: RMD) announced today the results from its 2023 Global Sleep Survey in conjunction with National Sleep Awareness Week (March 12-18) and World Sleep Day (March 17) to raise awareness for the importance of sleep as a key component of physical and mental health.

The survey found that despite 64% of respondents saying they are satisfied with the quantity of their sleep, more than 80% report experiencing symptoms of disruption related to their sleep quality, with consumers most commonly reporting mood changes, such as depression or irritability (33%), waking up with a dry mouth or sore throat (30%), difficulty concentrating during the day (30%), and excessive daytime sleepiness (29%).

The 2023 Global Sleep Survey asked more than 20,000 respondents from 12 countries during January 2023 about the quantity and quality of their sleep, bedtime routines, and sleep habits and found differences in respondents’ quantity and quality of sleep based on location, gender, and age:

  • Respondents from India (84%), Mexico (69%), and China (66%) are most satisfied with their quantity of sleep, while those in Australia (47%), Japan (46%), and the UK (45%) are the least satisfied with the quantity of their sleep.
  • 8 in 10 respondents reported one or more symptoms of sleep disruption related to sleep quality; Mexico (87%), France (87%), and South Korea (85%) had the highest rates of reported symptoms, while Japan (60%) had the lowest.
  • 60% of women report being satisfied with their quantity of sleep (the least of any gender), compared to 68% of men and 65% of nonbinary respondents. Women (83%) and nonbinary (94%) respondents were more likely to say they have at least one symptom of poor sleep compared to men (79%).
  • 52% of women report regularly waking up with a negative feeling in the morning (e.g. cranky, anxious, miserable), with 26% saying they’re still tired. Conversely, 58% of men report they are more likely to wake up feeling positive (e.g. happy, refreshed, calm, energetic).
  • 43% of Gen Xers and Boomers and 49% of the Silent Generation report that they aren’t satisfied with the quality of their sleep, compared to only 37% of Millennials and 31% of Gen Zers.

Despite a majority of survey respondents reporting they wake up with symptoms of poor sleep quality – one-third (33%) of respondents have not been tested for sleep apnea or sought medical help for other sleep conditions because they do not believe they have sleep-related medical conditions. Additionally, 49% of respondents said their doctor has never asked them proactively about their sleep quality.

“Prioritizing sleep is one of the most effective ways to improve your health, and poor sleep can increase the risk of diabetes, obesity, heart disease, and depression,” said Carlos M. Nunez, M.D., chief medical officer for ResMed. “It’s critical to have an honest discussion with your healthcare provider about your sleep habits and seek help if you’re experiencing patterns or symptoms of poor sleep as it could point to a more concerning health issue or sleep disorder such as sleep apnea.”

What’s Keeping People Up at Night and Tools They’re Using to Improve Their Sleep
Additional findings of ResMed’s 2023 Global Sleep Survey address what’s keeping people up at night and how people use technology to improve sleep. Findings include:

  • Amidst global reports of potential economic instability, anxiety/depression (33%) and work-related concerns (33%) are the two most cited reasons for keeping people up at night – an increase compared to a similar question asked in 2022 (29% and 22%, respectively).
  • Anxiety/depression was most commonly reported as the reason keeping people up at night in Brazil (46%), the U.S. (45%), Australia (42%), and the UK (42%) – and least reported in Japan (24%), India (22%), and Germany (21%).
  • Among consumers whose sleep has gotten worse over the past year, nearly one-third say financial pressures have caused the decline in their sleep quality (32%), with those in the U.S. (41%), Mexico (39%), and India (37%) reporting the highest impact.
  • 43% of Millennials report using a sleep tracker to keep records of their sleep patterns and quality of sleep, higher than Gen Z (35%), Gen X (28%), Boomers (15%), and the Silent Generation (7%).

To learn more about ResMed’s 2023 Global Sleep Survey or to take a quick self-assessment for your risk of sleep apnea, visit SleepForBetterTomorrow.com. Plus, learn about the digital health technologies that are transforming how we sleep, breathe, live, and care for patients on ResMed’s new podcast series, Awaken Your Best, hosted by Dr. Nunez and available anywhere you stream your favorite podcasts including on Spotify and Apple Podcasts. The first episode premiers today – Monday, March 13 – featuring a conversation on the latest digital health trends with Gary Shapiro, acclaimed author and president and CEO of the Consumer Technology Association.

Survey Methodology
ResMed 2023 Global Sleep Survey included 20,069 total participants across the United States, the United Kingdom, Germany, France, South Korea, Mexico, Japan, Singapore, Australia, Brazil, China, and India, conducted in January 2023.

For generational comparisons, the survey defines Gen Z as ages 18-26, Millennials ages 27-42, Gen X ages 43-58, Baby Boomers ages 59-77, and the Silent Generation ages 78-95.

About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies” and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

For media For investors
Kristin Deuber Amy Wakeham
+1 614.975.4186 +1 858.836.5000
resmed@allisonpr.com investorrelations@resmed.com

GlobeNewswire Distribution ID 8786245

Philips appoints Julia Strandberg as Chief Business Leader of the Connected Care businesses

March 13, 2023

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the appointment of Julia Strandberg as the Chief Business Leader of its Connected Care businesses, effective April 24, 2023. Ms. Strandberg will become a member of Philips’ Executive Committee reporting to Philips CEO Roy Jakobs. As of April 1, 2023, Philips’ Connected Care businesses will comprise the Monitoring, Sleep & Respiratory Care and Enterprise Informatics businesses.

Ms. Strandberg (American, 1974) joins Philips from Pear Therapeutics, where she served as the Chief Commercial Officer leading the commercial team that built, launched and grew their prescription digital therapeutics offering. Prior to this, Ms. Strandberg led a healthcare business consulting firm focused on driving client growth, and before this, she led Medtronic’s global Health Informatics and Monitoring business, and was the global marketing leader for the Patient Monitoring business within Covidien’s Respiratory & Monitoring group, which was acquired by Medtronic. Ms. Strandberg started her career at 3M, where she worked across a number of roles at the company.

“On behalf of Philips’ Executive Committee, I am delighted to announce that Julia Strandberg will join Philips as our new Chief Business Leader of the Connected Care businesses and member of the Executive Committee,” said Roy Jakobs, CEO of Royal Philips. “Julia brings deep, multi-disciplinary expertise, including in informatics and monitoring, to Philips. Passionate about improving the healthcare experience for patients and providers across care settings, Julia understands how to deliver in the global healthcare ecosystem and adds extensive experience in developing and commercializing medical technologies.”

Ms. Strandberg succeeds Dan Leonard, who took on the role of Chief Business Leader Connected Care ad interim when Roy Jakobs became CEO in October, 2022.

Philips’ strong brand and compelling purpose appeal to and attract talent, and the company has therefore continued to strengthen the organization with new health technology talent, including seasoned leaders with deep expertise. Ms. Strandberg ’s appointment to Philips’ Executive Committee builds on the recent appointments of Wim Appelo as Philips’ Chief Operations Officer and Steve C. de Baca as Philips’ Chief Patient Safety & Quality Officer, as well as the promotion of Jeff DiLullo to Philips’ Chief Market Leader of North America.

Additional information on Philips’ Executive Committee can be found here.

For further information, please contact:

Ben Zwirs
Philips Global Press Office
Tel.: +31 615213446
E-mail: ben.zwirs@philips.com

Derya Guzel
Philips Investor Relations
Tel.: +31 20 59 77055
E-mail: derya.guzel@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Forward-looking statements
This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.

Attachment

GlobeNewswire Distribution ID 1000797685

AFM has initiated an investigation into irregularities in trading of Azerion shares

Amsterdam, 13 March 2023 – Today Azerion has announced an investigation by the Autoriteit Financiële Markten (AFM), which according to AFM-information known to the Company, appears to be related to compliance with article 15 of the Market Abuse Regulation and seems to be focused on the shareholders of Principion Holding B.V., including Azerion co-CEOs Atilla Aytekin and Umut Akpinar. Principion is Azerion’s largest shareholder.

Based on the information available and the information provided by co-CEO Atilla Aytekin, he decided, in close consultation with the Supervisory Board, that the interests of the Company and its stakeholders are best served by him temporarily stepping aside at this moment in time from his duties and responsibilities as co-CEO of the Company.

The operational leadership of the Company remains with Azerion’s Executive Committee and broader leadership team, with Umut Akpinar as CEO and Ben Davey as CFO. This is a continuation of the current day-to-day practice for organic and inorganic activities. The team remains focused on fulfilling Azerion’s strategy and dedicated execution of the business plan.

The AFM approached Azerion on Tuesday 7 March 2023 to obtain information. The Company is fully available to answer any questions of the AFM.

The Supervisory Board has installed a Special Committee to steer the process and to be kept fully informed.

The Company is limited in its possibilities to provide further information pending the investigation, and will share information if and when appropriate.

About Azerion
Azerion is a high-growth digital entertainment and media platform. As a content-driven, technology and data company, Azerion serves consumers, digital publishers, advertisers, and game creators globally. Azerion’s integrated platform provides technology solutions to automate the purchase and sale of digital advertising for media buyers and sellers, supported by in-market sales and campaign management teams. Through our technology, content creators, digital publishers and advertisers work with Azerion to reach the millions of people across the globe that play Azerion’s games and view its distributed entertainment content to increase engagement, loyalty, and drive e-commerce.

Founded in 2014 by two Dutch entrepreneurs, Azerion has experienced rapid expansion driven by organic growth and strategic acquisitions. Azerion is headquartered in Amsterdam, the Netherlands and is a publicly traded company listed on Euronext Amsterdam.

This press release contains information that qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

For more information visit: www.azerion.com

Contact
Investor Relations
ir@azerion.com

Media
press@azerion.com

DISCLAIMER

The companies in which Azerion Group N.V. directly and indirectly owns investments are separate legal entities. In this announcement “Azerion”, “Azerion Group”, “Company” and “Group” are sometimes used for convenience where references are made to Azerion Group N.V. and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to Azerion Group N.V. and its subsidiaries in general or to those who work for them.

This press release is for information purposes only. The information contained in this press release does not purport to be full or complete and, in particular, is not intended to form the basis of any investment decision. No reliance may be placed by any person for any purpose on the information contained in this press release or its accuracy, fairness or completeness. Azerion will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided.

This press release may include forward-looking statements. All statements other than statements of historical facts may be forward-looking statements. Words and expressions such as believes, estimates, plans, projects, anticipates, expects, intends, may, will, should or other similar words or expressions are typically used to identify forward-looking statements. Forward-looking statements are subject to risks, uncertainties and other factors that are difficult to predict and that may cause the actual results of Azerion to differ materially from future results expressed or implied by such forward-looking statements. Any forward-looking statements reflect Azerion’s current views and assumptions based on information currently available to Azerion’s management. Forward-looking statements speak only as of the date they are made, and Azerion does not assume any obligation to update such statements, except as required by law. No assurances can be given that the forward-looking statements will be realised. No representation or warranty is made that any of these forward-looking statements will come to pass or that any estimated result will be achieved. Accordingly, no undue reliance should be placed on any forward-looking statements.

GlobeNewswire Distribution ID 1000797634

Where is your squid coming from? Most likely unregulated waters, according to a new international study

New research fuses multiple data sources to advance understanding of the expanding footprint of global squid fleets

Washington, D.C., March 10, 2023 (GLOBE NEWSWIRE) — Scientists and policymakers have voiced growing concerns about the decline of global squid stocks, but little has been done to date to target squid fishing activities that are expanding into unregulated spaces, according to a new international study.

The study, lead-authored by Katherine Seto, an assistant professor of environmental studies at the University of California, Santa Cruz, was published in Science Advances on March 10. It explores the unregulated nature of global squid fisheries across three oceans over a three-year period, and how these fisheries continue to grow and shift locations beyond the jurisdiction of management bodies. The research was conducted through a research partnership between Global Fishing Watch, the Australian National Centre for Ocean Resources and Security at the University of Wollongong, and the Japan Fisheries Research and Education Agency.

Using satellite imagery, vessel tracking, and data monitoring, the study found that the fishing conducted by this globalized light-luring squid fishery was extensive, fishing between 149,000-251,000 vessel days annually, and that effort increased 68% over the study period from 2017-2020.

“These squid fisheries are highly mobile, fishing multiple oceans within a given year,” said Seto. “While some conservation and management measures are in place to regulate this type of fishing, our research found that actors may take advantage of these fragmented regulations to maximize resource extraction. To address this, we need to address the factors that promote the growth and expansion of fishing efforts, and increase data sharing and communication between management entities.”

The study found that these squid fishing vessels fished largely (86%) in unregulated areas, equating to 4.4 million total hours of fishing time between 2017-2020. While unregulated fishing is not necessarily illegal, it presents challenges for fisheries sustainability and resource equity, and has been connected to questionable human rights and labor practices.

“By synthesizing data from multiple sources, we created a robust picture of the fishing activity of the high seas squid fleets. Our analysis highlights the interconnectedness of fishing grounds used by the fleets,” said Nate Miller, head of applied research at Global Fishing Watch and co-author of the study. “It demonstrates the critical importance of comprehensive data sharing agreements between regional bodies for improving understanding of the movements of these vessels and quantifying their impacts on squid stocks.”

One major challenge has been the vessels freely fishing between regulated and unregulated spaces, fishing huge amounts of squid with little to no oversight or data reporting. Fishing in unregulated areas has also steadily increased and seems to be preferred despite concerns over stock status, according to the study.

“These unregulated fishing activities require urgent action. They occur in our global commons, shared by all, yet few receive any benefit, and neighboring coastal States are increasingly concerned regarding the impact on their own shared fish stocks,” said study co-author Quentin Hanich, from the University of Wollongong.

Masanori Miyahara, a co-author and advisor to the Minister of Agriculture, Forestry and Fisheries of Japan, agrees.

“These catches are often not reported to domestic or international management bodies, nor are they incorporated into estimates of fishing effort, harvest, or stock status,” said Miyahara. “While it is good to see both the North Pacific Fisheries Commission and the South Pacific Regional Fisheries Management Organisation strengthen their management, urgent responses are also required in the Indian and Atlantic Oceans to ensure that fleets do not simply evade regulation by moving elsewhere.”

As we experience an increased demand for seafood products globally, we must understand the factors that facilitate the increase and expansion of fishing efforts to address the challenges of unregulated fishing, according to the study.

“Like all activities in the global commons, fishing on the high seas should be fully regulated. Yet the regional bodies with the competence to adopt management measures are restrained by a handful of states whose self-interests are best served when such activities are unregulated or done with few limits,” said Osvaldo Urrutia S., professor of international law at Pontificia Universidad Católica de Valparaíso in Chile. “The global squid fishery shows how important it is to strengthen regional management of high seas resources and to continue international calls for states and regional bodies to take this challenge seriously.”

Attachment

Lisa Tossey
Global Fishing Watch
3024486638
lisa.tossey@globalfishingwatch.org

GlobeNewswire Distribution ID 8785747

Gorilla Technology Chosen to Participate in UK Tech Delegation Visit to Southeast Asia

One of 15 innovative companies selected to meet with business and government leaders in the region

LONDON, March 10, 2023 (GLOBE NEWSWIRE) — Gorilla Technology Group Inc. (“Gorilla”) (NASDAQ: GRRR), a global provider of AI based edge video analytics, IoT technologies, and cybersecurity, today announced it is one of a select group of companies chosen to participate in the first ever UK-Southeast Asia Tech Week, sponsored by the UK Department for Business and Trade (DBT).

The DBT will lead the delegation of 15 innovative UK technology companies offering best-in-class, export ready solutions in the Net Zero and Internet of Things sectors, including Gorilla, to Jakarta, Indonesia and Bangkok, Thailand from March 13 to March 20 for a series of commercially focused engagements with influential businesses and government representatives from across the region.

“We are honored to accompany the UK Department for Business and Trade and several fellow innovative companies for this important opportunity to build relationships and exchange ideas with leaders and officials in the region. This region continues to be of significant interest for Gorilla as we pursue our global expansion strategy,” said Gorilla Chairman and CEO, Jay Chandan.

During the delegation’s visit, Gorilla will have an opportunity to participate in one-on-one matching sessions with targeted potential partners and customers; on-site visits to local organizations and companies; workshops and roundtables on the ASEAN tech landscape and local market requirements; and networking events with key business leaders and influential government officials.

Natalie Black, His Majesty’s Trade Commissioner for Asia Pacific, said: “I am pleased to welcome Gorilla Technology to Southeast Asia as part of a delegation of cutting-edge UK tech companies. Southeast Asia is an important region for the UK, with a digital economy projected to exceed US$360bn by 2025. I look forward to witnessing new and growing relationships unfold following UK-Southeast Asia Tech Week.”

About Gorilla Technology Group Inc.
Gorilla, headquartered in London, is a global solution provider in security intelligence, network intelligence, business intelligence and IoT technology. Gorilla develops a wide range of solutions including Smart Cities, Smart Retail, Enterprise Security, and Smart Media. In addition, Gorilla provides a complete Security Convergence Platform to government institutions, telecom companies and private enterprises with network surveillance and cyber security.

Gorilla places an emphasis on offering leading technology, expert service, and precise delivery, and ensuring top-of-the-line, intelligent and strong edge AI solutions that enable clients to improve operational performance and efficiency. With continuous core technology development, Gorilla will deliver edge AI solutions to managed service providers, distributors, system integrators, and hardware manufacturers.
Gorilla-Technology.com

No Offering of Securities
This press release does not constitute an offer to sell or exchange, or the solicitation of an offer to buy or exchange, any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, sale or exchange would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

Forward-Looking Statements
This press release contains forward-looking statements, which are based on estimates, assumptions, and expectations. Actual results and performance could differ materially and adversely from those expressed or implied in forward-looking statements. Gorilla does not undertake any obligation to update any forward-looking statements, except as required by law.

Contact:
Jeff Fox
The Blueshirt Group for Gorilla
415-828-8298
jeff@blueshirtgroup.com

GlobeNewswire Distribution ID 8786080